| Q39698048 | A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model |
| Q35946229 | A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology |
| Q92506383 | A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus (RSV) Infe |
| Q38797620 | A Simple Screening Approach To Prioritize Genes for Functional Analysis Identifies a Role for Interferon Regulatory Factor 7 in the Control of Respiratory Syncytial Virus Disease |
| Q95326762 | A gammaherpesvirus licenses CD8 T cells to protect the host from pneumovirus-induced immunopathologies |
| Q35050237 | A gene expression signature for RSV: clinical implications and limitations. |
| Q37252613 | A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice |
| Q40380870 | A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice |
| Q33648976 | A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants. |
| Q39027049 | Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection |
| Q28554809 | Actin-Related Protein 2 (ARP2) and Virus-Induced Filopodia Facilitate Human Respiratory Syncytial Virus Spread |
| Q24646833 | Activation of innate immune antiviral responses by Nod2 |
| Q45396723 | Activation of the granzyme pathway in children with severe respiratory syncytial virus infection |
| Q37764005 | Adaptive immune responses mediated by natural killer cells |
| Q36540154 | Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development |
| Q36126322 | Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice |
| Q35157041 | An overview of respiratory syncytial virus. |
| Q35159747 | Animal models of human respiratory syncytial virus disease |
| Q39026362 | Animal models of respiratory syncytial virus infection |
| Q34454614 | Antiviral B cell and T cell immunity in the lungs. |
| Q38076312 | Apoptosis in pneumovirus infection |
| Q47548120 | Aryl hydrocarbon receptor signaling modulates antiviral immune responses: ligand metabolism rather than chemical source is the stronger predictor of outcome |
| Q36212118 | Association of Higher MERS-CoV Virus Load with Severe Disease and Death, Saudi Arabia, 2014. |
| Q44006155 | Association of the CT values of real-time PCR of viral upper respiratory tract infection with clinical severity, Kenya |
| Q35076663 | Ataxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection. |
| Q38721807 | BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection. |
| Q34504791 | Biological challenges and technological opportunities for respiratory syncytial virus vaccine development |
| Q35076807 | Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo |
| Q35937976 | Building a better neonatal mouse model to understand infant respiratory syncytial virus disease. |
| Q34055489 | CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection |
| Q38249619 | CD8+ T cell immunity against human respiratory syncytial virus |
| Q52339069 | Central Role of the NFκB Pathway in the Scgb1a1-Expressing Epithelium in Mediating Respiratory Syncytial Virus-induced Airway Inflammation. |
| Q26853354 | Challenges and future in vaccines, drug development, and immunomodulatory therapy |
| Q30300567 | Challenges and opportunities in developing respiratory syncytial virus therapeutics |
| Q34450231 | Characterization of the resistance of SJL/J mice to pneumonia virus of mice, a model for infantile bronchiolitis due to a respiratory syncytial virus |
| Q36839725 | Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection. |
| Q93074012 | Clinical correlation of influenza and respiratory syncytial virus load measured by digital PCR |
| Q34698775 | Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8⁺ T cell response |
| Q42208207 | Comparison of virological profiles of respiratory syncytial virus and rhinovirus in acute lower tract respiratory infections in very young Chilean infants, according to their clinical outcome |
| Q33754172 | Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responses |
| Q40813276 | Control of influenza infection is impaired by diminished interferon-γ secretion by CD4 T cells in the lungs of toddler mice. |
| Q36015918 | Cytokine Profiles in Human Metapneumovirus Infected Children: Identification of Genes Involved in the Antiviral Response and Pathogenesis |
| Q59356281 | Cytokines and CD8 T cell immunity during respiratory syncytial virus infection |
| Q35082211 | DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway |
| Q26764790 | Determinants of early life immune responses to RSV infection |
| Q37713960 | Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model |
| Q57093491 | Differential Induction of IFN-α and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-γ Response to Influenza A Viruses |
| Q39789193 | Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells. |
| Q42250476 | Differential lung NK cell responses in avian influenza virus infected chickens correlate with pathogenicity |
| Q40540282 | Differential mucosal IL-10-induced immunoregulation of innate immune responses occurs in influenza infected infants/toddlers and adults |
| Q37227455 | Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection |
| Q37003960 | Differential response of BDCA-1+ and BDCA-3+ myeloid dendritic cells to respiratory syncytial virus infection |
| Q27322383 | Early responses of natural killer cells in pigs experimentally infected with 2009 pandemic H1N1 influenza A virus |
| Q42818822 | Effect of inhaled hypertonic saline on hospital admission rate in children with viral bronchiolitis: a randomized trial |
| Q33655089 | Effects of aging on the adaptive immune response to respiratory virus infections. |
| Q39934439 | Emergency Department Septic Screening in Respiratory Syncytial Virus (RSV) and Non-RSV Bronchiolitis |
| Q64277586 | Emerging Regulatory Roles of Dual-Specificity Phosphatases in Inflammatory Airway Disease |
| Q34178147 | Epitope-Specific Regulatory CD4 T Cells Reduce Virus-Induced Illness while Preserving CD8 T-Cell Effector Function at the Site of Infection |
| Q38162418 | Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity |
| Q64060972 | Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease |
| Q40721101 | Functional correlations of respiratory syncytial virus proteins to intrinsic disorder. |
| Q35383245 | Galectin-1 binds to influenza virus and ameliorates influenza virus pathogenesis |
| Q47555012 | Haemophilus is overrepresented in the nasopharynx of infants hospitalized with RSV infection and associated with increased viral load and enhanced mucosal CXCL8 responses. |
| Q90401234 | Host Components Contributing to Respiratory Syncytial Virus Pathogenesis |
| Q40718006 | Human CD8(+) T Cells Target Multiple Epitopes in Respiratory Syncytial Virus Polymerase |
| Q36943137 | Human genetic factors and respiratory syncytial virus disease severity |
| Q37340604 | Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs. |
| Q59359632 | Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches |
| Q34264615 | Immunity to RSV in Early-Life. |
| Q34960945 | Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants |
| Q34043293 | Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse |
| Q90681995 | Impact of Respiratory Syncytial Virus Infection on the Host Cell: Implications for Antiviral Strategies |
| Q30512964 | In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo |
| Q37137188 | Inchoate CD8+ T cell responses in neonatal mice permit influenza-induced persistent pulmonary dysfunction |
| Q52649839 | Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus. |
| Q36764722 | Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants |
| Q26799729 | Influenza A Virus Infection, Innate Immunity, and Childhood |
| Q42546477 | Influenza virus directly infects human natural killer cells and induces cell apoptosis |
| Q40338951 | Inhibition of human natural killer cell activity by influenza virions and hemagglutinin |
| Q30365302 | Innate immune sensing and response to influenza. |
| Q27489605 | Innate immunity to influenza virus: implications for future therapy |
| Q39248967 | KLF6 and iNOS regulates apoptosis during respiratory syncytial virus infection |
| Q35862041 | Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants |
| Q34630095 | LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity |
| Q54248394 | Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium. |
| Q34059301 | Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection. |
| Q47427817 | Localization of the T-cell response to RSV infection is altered in infant mice. |
| Q41663028 | Lung dendritic cell developmental programming, environmental stimuli, and asthma in early periods of life |
| Q35070732 | Mechanical ventilation drives inflammation in severe viral bronchiolitis |
| Q37086274 | Mechanical ventilation enhances lung inflammation and caspase activity in a model of mouse pneumovirus infection |
| Q36203787 | Mechanisms of respiratory syncytial virus modulation of airway immune responses |
| Q47238680 | Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection. |
| Q36191671 | Memory CD8+ T cells are sufficient to alleviate impaired host resistance to influenza A virus infection caused by neonatal oxygen supplementation |
| Q35834816 | Mice with asthma are more resistant to influenza virus infection and NK cells activated by the induction of asthma have potentially protective effects. |
| Q26782421 | Modeling Influenza Virus Infection: A Roadmap for Influenza Research |
| Q45349488 | Modeling respiratory syncytial virus cytopathogenesis in the human airway |
| Q38214645 | Modulation of Respiratory TLR3-Anti-Viral Response by Probiotic Microorganisms: Lessons Learned from Lactobacillus rhamnosus CRL1505. |
| Q37599884 | Motavizumab for the prevention of respiratory syncytial virus infection in infants |
| Q37179280 | Mucosal antibody responses are directed by viral burden in children with acute influenza infection |
| Q33489541 | NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection |
| Q90229650 | NK Cell Hyporesponsiveness: More Is Not Always Better |
| Q89884849 | Natural killer cell activation by respiratory syncytial virus-specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc-glycosylation |
| Q38061192 | Natural killer cells in hepatitis C virus infection. |
| Q28391714 | Natural killer cells in infection and inflammation of the lung |
| Q40952436 | Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease |
| Q38567537 | Neutrophils in respiratory syncytial virus infection: A target for asthma prevention |
| Q34249859 | New insights for development of a safe and protective RSV vaccine |
| Q38539476 | New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus. |
| Q30403195 | Novel H1N1 influenza in neonates: from mild to fatal disease |
| Q41841268 | Novel clinical features of recurrent human respiratory syncytial virus infections |
| Q35384114 | Parainfluenza virus infections in children with hematologic malignancies |
| Q36115091 | Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway |
| Q36808322 | Pneumonia virus of mice: severe respiratory infection in a natural host |
| Q28354138 | Pneumovirus-Induced Lung Disease in Mice Is Independent of Neutrophil-Driven Inflammation |
| Q40144736 | Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor |
| Q58806120 | Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina |
| Q41819020 | Preliminary evaluation of a multiplex reverse transcription-PCR assay combined with a new DNA chip hybridization assay for detecting respiratory syncytial virus |
| Q36274090 | Prenatal Exposure to Respiratory Syncytial Virus Alters Postnatal Immunity and Airway Smooth Muscle Contractility during Early-Life Reinfections |
| Q37461377 | Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response |
| Q56894869 | Progress in respiratory virus vaccine development |
| Q35566601 | Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years |
| Q37071608 | Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus. |
| Q93211027 | RSV Reprograms the CDK9•BRD4 Chromatin Remodeling Complex to Couple Innate Inflammation to Airway Remodeling |
| Q30577192 | RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction |
| Q36655719 | Rapid Evolution of the CD8+ TCR Repertoire in Neonatal Mice |
| Q26825438 | Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus |
| Q33635085 | Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves. |
| Q36667922 | Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice |
| Q37127882 | Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities |
| Q35531231 | RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection |
| Q42276206 | Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium |
| Q40760956 | Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology |
| Q40321692 | Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity |
| Q41166298 | Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation. |
| Q57461131 | Respiratory Syncytial Virus-induced Acute Disease Severity and Long-Term Wheezing. Uncovering the Unexpected |
| Q52380909 | Respiratory Viruses and Asthma. |
| Q34397659 | Respiratory morbidity and lung function in preterm infants of 32 to 36 weeks' gestational age. |
| Q38258808 | Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis |
| Q59351960 | Respiratory syncytial virus (RSV) infects primary neonatal and adult natural killer cells and affects their anti-viral effector function |
| Q40465877 | Respiratory syncytial virus induces phosphorylation of mTOR at ser2448 in CD8 T cells from nasal washes of infected infants. |
| Q36236921 | Respiratory syncytial virus infection down-regulates antioxidant enzyme expression by triggering deacetylation-proteasomal degradation of Nrf2. |
| Q37365383 | Respiratory syncytial virus infection induces a reactive oxygen species-MSK1-phospho-Ser-276 RelA pathway required for cytokine expression |
| Q38365417 | Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs |
| Q36444085 | Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities |
| Q33714072 | Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs |
| Q38945689 | Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression |
| Q37857806 | Respiratory syncytial virus prevention and therapy: past, present, and future |
| Q59351084 | Respiratory syncytial virus vaccine: where are we now and what comes next? |
| Q38098094 | Respiratory syncytial virus--a comprehensive review |
| Q33852442 | Respiratory syncytial virus: a prioritized or neglected target? |
| Q33591243 | Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology |
| Q37340452 | Respiratory viruses and eosinophils: exploring the connections. |
| Q24655957 | Respiratory viruses other than influenza virus: impact and therapeutic advances |
| Q34089255 | Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope |
| Q40749296 | Robust Cytokine and Chemokine Response in Nasopharyngeal Secretions: Association With Decreased Severity in Children With Physician Diagnosed Bronchiolitis |
| Q38507225 | Role of IL-25 in Immunity |
| Q42043917 | Role of T cells in virus control and disease after infection with pneumonia virus of mice |
| Q34120066 | Role of peroxiredoxin 1 and peroxiredoxin 4 in protection of respiratory syncytial virus-induced cysteinyl oxidation of nuclear cytoskeletal proteins |
| Q30413489 | Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses |
| Q63880645 | Standardization and validation of assays determining cellular immune responses against influenza |
| Q27334724 | Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection |
| Q33832308 | Subversion of pulmonary dendritic cell function by paramyxovirus infections |
| Q34025263 | Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells |
| Q30392760 | Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus |
| Q40309226 | Systematic Analysis of Cell-Type Differences in the Epithelial Secretome Reveals Insights into the Pathogenesis of Respiratory Syncytial Virus-Induced Lower Respiratory Tract Infections |
| Q26798272 | Systems biology from virus to humans |
| Q37067433 | T-cell immunoglobulin and mucin domain 1 deficiency eliminates airway hyperreactivity triggered by the recognition of airway cell death |
| Q35056722 | TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization |
| Q58571106 | Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection |
| Q55101403 | The CD8 T Cell Response to Respiratory Virus Infections. |
| Q39127064 | The Human Immune Response to Respiratory Syncytial Virus Infection |
| Q36482753 | The Pneumonia Virus of Mice (PVM) model of acute respiratory infection |
| Q41921750 | The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, versus its achievable concentrations in the human respiratory tract and comparison to ribavirin. |
| Q35363216 | The caspase inhibitor zVAD increases lung inflammation in pneumovirus infection in mice |
| Q36055988 | The human side of influenza |
| Q94601820 | The immune response to influenza in older humans: beyond immune senescence |
| Q36994294 | The immune response to respiratory syncytial virus infection: friend or foe? |
| Q27026381 | The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses |
| Q39014478 | The neonatal immune system: immunomodulation of infections in early life |
| Q40796643 | The protective effects of intranasal administration of IL-12 given before influenza virus infection and the negative effects of IL-12 treatment given after viral infection |
| Q41511965 | The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies |
| Q36994686 | The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes |
| Q34549253 | The use of a neonatal mouse model to study respiratory syncytial virus infections |
| Q38650711 | Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor |
| Q40051899 | Tissue compartmentalization of T cell responses during early life |
| Q36083900 | Transactivation of inducible nitric oxide synthase gene by Kruppel-like factor 6 regulates apoptosis during influenza A virus infection |
| Q41231990 | Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection |
| Q38140040 | Translational sciences approach to RSV vaccine development |
| Q91665841 | Type I IFN ineffectively activates neonatal dendritic cells limiting respiratory antiviral T-cell responses |
| Q64229661 | Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection |
| Q36397412 | Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice |
| Q37018347 | Vaccines against respiratory syncytial virus: The time has finally come |
| Q64106116 | Viral Infection of Human Natural Killer Cells |
| Q39118448 | Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation |
| Q36155439 | Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants |
| Q36483836 | Viral and host factors in human respiratory syncytial virus pathogenesis |
| Q31144301 | Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection |
| Q43511331 | Why is RSV different from other viruses? |
| Q90689063 | β2 integrin LFA1 mediates airway damage following neutrophil trans-epithelial migration during RSV infection |